Literature DB >> 15227262

Coronary histology after percutaneous transluminal coronary angioplasty.

V La Delia1, P A Rossi, S Sommers, E Kreps.   

Abstract

This article describes previously unreported histologic changes in the vessels of a patient who was admitted with an evolving myocardial infarction due to subtotal occlusion of the left anterior descending coronary artery. The patient died of cardiogenic shock 15 hours after undergoing a technically successful percutaneous transluminal coronary angioplasty procedure. Upon early postmortem study, histologic sections from the proximal, middle, and distal thirds of the left anterior descending coronary artery were polymorphic in appearance. Sections from the most proximal angioplasty site revealed intimal proliferation of polymorphonuclear leukocytes, as well as intimal fibrosis with plaque cleavage. Sections from the more distal angioplasty sites revealed plaque cleavage, intimal polymorphonuclear infiltration, and intimal, medial, and adventitial fracture with dissecting hemorrhage, although mural integrity had been maintained. Intense subintimal proliferation with inflammatory cells has previously been described only in an experimental animal model. Our case also appears to be the first in which adventitial disruption has been observed after percutaneous transluminal coronary angioplasty; this finding provides new evidence that an atherosclerotic coronary artery can tolerate vigorous dilatation without rupture.

Entities:  

Year:  1988        PMID: 15227262      PMCID: PMC324802     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  10 in total

1.  Morphology after transluminal angioplasty in human beings.

Authors:  P C Block; R K Myler; S Stertzer; J T Fallon
Journal:  N Engl J Med       Date:  1981-08-13       Impact factor: 91.245

2.  Mechanical effect of balloon angioplasty: case report with histology.

Authors:  M E Clouse; J F Tomashefski; R E Reinhold; P Costello
Journal:  AJR Am J Roentgenol       Date:  1981-10       Impact factor: 3.959

3.  Transluminal coronary angioplasty of postmortem human hearts.

Authors:  K L Baughman; R C Pasternak; J T Fallon; P C Block
Journal:  Am J Cardiol       Date:  1981-12       Impact factor: 2.778

Review 4.  Release of inflammatory mediators from stimulated neutrophils.

Authors:  G Weissmann; J E Smolen; H M Korchak
Journal:  N Engl J Med       Date:  1980-07-03       Impact factor: 91.245

5.  Scanning electron microscopy after coronary transluminal angioplasty of normal canine coronary arteries.

Authors:  R C Pasternak; K L Baughman; J T Fallon; P C Block
Journal:  Am J Cardiol       Date:  1980-03       Impact factor: 2.778

6.  Acute effects of transluminal angioplasty in three experimental models of atherosclerosis.

Authors:  D P Faxon; V J Weber; C Haudenschild; S B Gottsman; W A McGovern; T J Ryan
Journal:  Arteriosclerosis       Date:  1982 Mar-Apr

7.  Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty.

Authors:  G E Austin; N B Ratliff; J Hollman; S Tabei; D F Phillips
Journal:  J Am Coll Cardiol       Date:  1985-08       Impact factor: 24.094

8.  Thromboxane A2 in vasotonic angina pectoris: evidence from direct measurements and inhibitor trials.

Authors:  R M Robertson; D Robertson; L J Roberts; R L Maas; G A FitzGerald; G C Friesinger; J A Oates
Journal:  N Engl J Med       Date:  1981-04-23       Impact factor: 91.245

9.  Evaluation of transluminal angioplasty of chronic coronary artery stenosis. Value and limitations assessed in fresh human cadaver hearts.

Authors:  G Lee; R M Ikeda; J A Joye; H G Bogren; A N DeMaria; D T Mason
Journal:  Circulation       Date:  1980-01       Impact factor: 29.690

10.  Effects of leukotrienes B4 and C4 on coronary circulation and myocardial contractility.

Authors:  F Michelassi; G Castorena; R D Hill; E Lowenstein; W D Watkins; A J Petkau; W M Zapol
Journal:  Surgery       Date:  1983-08       Impact factor: 3.982

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.